Amy Penticoff

[section title=”Three Columns With Header” id=”section4″ wide=true typography_md=”Text {line-height: 22.85714286px;font-size: 16px;}H3 {line-height: 28.57142858px;font-size: 20px;}” typography_sm=”Text {line-height: 22.85714286px;font-size: 16px;}H3 {line-height: 22.85714286px;font-size: 16px;}” typography_xs=”Text {line-height: 23.8px;}H1 {line-height: 51.42857144px;font-size: 36px;}” css=”padding-bottom:3em;padding-top:1em;” typography=”Text {line-height: 30.6px;text-align: center;color: #555555;font-size: 18px;font-weight: 400;}H4 {color: #002061;}H3 {line-height: 34.2857143px;font-size: 24px;font-weight: 600;text-transform: uppercase;}H1 {line-height: 85.71428574px;text-transform: uppercase;font-size: 60px;font-weight: normal;letter-spacing: 1px;}”]
[background_width][columns auto_height=1 vertical_align=”top” add_margins=true spacing_css_xs=”margin-top:-15px;margin-bottom:-15px;padding-top:15px;padding-bottom:15px;height:calc(130%);” spacing_css=”height:calc(110%);margin:-5px;padding:5px;”]
[column width_xs=”12″ css_xs=”padding:10px;” css=”padding:1em;”]
[image_scaling css=”background-position:right center;background-repeat:no-repeat;background-size:cover;”]
[image image_style=”imagestyles-23″ image=”https://amphivena.com/wp-content/uploads/2019/05/amphivena-amy.png” css_xs=”width:75%;” css=”width:20%;”][/image][/image_scaling]

[text tag=”h4″ typography_xs=”Text {line-height: 34.2857143px;font-size: 24px;}” typography=”Text {line-height: 42.85714287px;font-family: Lato, Arial, ‘Arial Unicode MS’, Helvetica, sans-serif;font-size: 30px;}”]Amy Penticoff, MBA[/text]

[text tag=”h4″ typography_xs=”Text {line-height: 28.57142858px;font-size: 20px;}” typography=”Text {line-height: 28.57142858px;font-family: Lato, Arial, ‘Arial Unicode MS’, Helvetica, sans-serif;font-size: 20px;}”]Vice President, Technical Operations[/text]

[separator content_type=”none” text=”Caption” text_tag=”span” align=”center” content_align=”center” href=”#” image=”https://cstatic.themler.io/themler/483/images/defaultImage.jpg” css=”padding:20px 0px;” image_css=”display:inline-block;” content_css=”margin-left:30px;margin-right:30px;” content_typography=”Text {color: #777777;}” line_css=”width:25%;border-top:1px solid #dddddd;”][/separator]

[text tag=”p” css_xs=”width:100%;” css=”width:70%;display:inline-block;” typography=”Text {line-height: 35px;text-align: justify;}”]Amy brings 30 years of product development, manufacturing, quality control, regulatory strategy and supply chain of small molecule and biologic drugs to Amphivena. Most recently she was a senior member of the Technical Operations team at ARMO BioSciences (now Eli Lilly), where she was responsible for Pegilodecakin and anti-PD-1 mAb drug product manufacture in support of the company’s clinical trials, as well as the development of the Pegilodecakin prefilled syringe. Following ARMO’s acquisition, Ms Penticoff oversaw the transfer of the product manufacturing technology from ARMO to Eli Lilly. Prior to ARMO, she served as Sr. Director of supply chain at Intarcia Therapeutics where she worked on a peptide based implantable product for the treatment of diabetes and development of a sterile implantation kit intended for commercialization. Before that, she was Director of Pharmaceutical Sciences at NeurogesX, Inc., supporting the development and commercialization of the QUTENZA® Dermal Patch. She also held various technical and managerial roles at SRI International, AP Pharma (now Heron Therapeutics), Oral-B Laboratories (now Gillette), Clorox and Dow Corning (now DowDupont). Ms. Penticoff holds a B.S. in Chemistry from the University of Illinois, Urbana-Champaign and an MBA from Pepperdine University, CA and holds patents in formulation and manufacturing.[/text]
[/column]
[/columns][/background_width]
[/section]

[section title=”Three Columns With Header” id=”section4″ wide=true typography_md=”Text {line-height: 22.85714286px;font-size: 16px;}H3 {line-height: 28.57142858px;font-size: 20px;}” typography_sm=”H3LinkPassive {line-height: 22.85714286px;font-size: 16px;}” typography_xs=”Text {line-height: 23.8px;}H1 {line-height: 51.42857144px;font-size: 36px;}” css=”padding-bottom:0em;padding-top:1em;background-color:#ffffff;” typography=”Text {line-height: 27.2px;text-align: center;color: #002061;font-size: 16px;font-weight: 400;font-family: Lato, Arial, ‘Arial Unicode MS’, Helvetica, sans-serif;}TextLinkPassive {color: #002061;}TextLinkHovered {color: #0070c0;}H3 {line-height: 25.71428573px;font-size: 18px;font-weight: 600;text-transform: uppercase;color: #002061;}H3LinkPassive {line-height: 22.85714286px;font-size: 16px;}H1 {line-height: 42.85714287px;text-transform: uppercase;font-size: 30px;letter-spacing: 1px;font-style: normal;font-weight: 600;color: #002061;font-family: Lato, Arial, ‘Arial Unicode MS’, Helvetica, sans-serif;}”]
[columns auto_height=1 vertical_align=”top” add_margins=true spacing_css_xs=”margin-top:-15px;margin-bottom:-15px;padding-top:15px;padding-bottom:15px;height:calc(130%);” spacing_css=”height:calc(110%);margin:-5px;padding:5px;”]
[column width_xs=”12″]
[html ]

[/html]

[text tag=”h1″ typography=”Text {font-weight: normal;font-family: Lato, Arial, ‘Arial Unicode MS’, Helvetica, sans-serif;color: #0070c0;}”]Leadership[/text]

[separator content_type=”none” text=”Caption” text_tag=”span” align=”center” content_align=”center” href=”#” image=”https://cstatic.themler.io/themler/480/images/defaultImage.jpg” css=”padding:10px 0px;” image_css=”display:inline-block;” content_css=”margin-left:30px;margin-right:30px;” content_typography=”Text {color: #777777;}” line_css_xs=”width:10%;” line_css=”width:5%;border-top:2px solid #000000;”][/separator]
[/column]

[column width_sm=”3″ css=”padding:1em;”]
[image href=”https://amphivena.com/curtis-l-ruegg-bio/” target=”_self” alt=”Curtis L. Ruegg” image=”https://amphivena.com/wp-content/uploads/amphivena-therapeutics-ceo-curtis-l-ruegg-phd.jpg” css_sm=”width:150px;height:155px;” css=”height:195px;width:195px;”][/image]

[text tag=”h3″ css=”margin-bottom:0px;” typography=”Text {line-height: 25.71428572px;font-size: 18px;}”]Curtis Ruegg, Ph.D.
[/text]

[text tag=”p” css=”margin-top:0px;margin-bottom:0px;”]CEO & President[/text]
[/column]

[column width_sm=”3″ css=”padding:1em;”]
[image href=”https://amphivena.com/victoria-smith-bio/” target=”_self” alt=”Victoria Smith” image=”https://amphivena.com/wp-content/uploads/2019/05/amphivena-victoria.png” css_sm=”width:145px;height:156px;” css=”width:180px;height:193px;”][/image]

[text tag=”h3″ css=”margin-bottom:0px;” typography=”Text {line-height: 25.71428572px;font-size: 18px;}”]


Victoria Smith, Ph.D.
[/text]

[text tag=”p” css=”margin-top:0px;”]


Chief Scientific Officer [/text]
[/column]

[column width_sm=”3″ css=”position:relative;padding:1em;”]
[image href=”https://amphivena.com/patrick-chun-bio/” target=”_self” alt=”Patrick Chun” image=”https://amphivena.com/wp-content/uploads/2019/07/amphivena-patrick-web.jpg” css_sm=”width:150px;height:152px;” css=”height:193px;width:191px;”][/image]

[text tag=”h3″ css=”margin-bottom:1px;” typography=”Text {line-height: 25.71428572px;font-size: 18px;}”]


Patrick Chun, M.D.
[/text]

[text tag=”p” css=”margin-top:1px;margin-bottom:0px;”]


Vice President[/text]

[text tag=”p” css=”margin-top:-8px;”]Clinical Development [/text]
[/column]

[column width_sm=”3″ css=”position:relative;padding:1em;”]
[image href=”https://amphivena.com/amy-penticoff-bio/” target=”_self” alt=”Amy Penticoff” image=”https://amphivena.com/wp-content/uploads/2019/05/amphivena-amy.png” css_sm=”width:150px;height:154px;” css=”width:189px;height:194px;”][/image]

[text tag=”h3″ css=”margin-bottom:0px;” typography=”Text {line-height: 25.71428572px;font-size: 18px;}”]


Amy penticoff, MBA
[/text]

[text tag=”p” css=”margin-top:0px;margin-bottom:0px;”]


Vice President[/text]

[text tag=”p” css=”margin-top:-8px;”]Technical Operations [/text]
[/column]
[/columns]
[/section]